Regional Insights
On the basis of Geography, the
global Medical
Grade Hydrogel Market is segmented into North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa. North America is expected to
lead the medical grade hydrogel market during forecast period, owing to high
number of plastic and reconstructive surgeries that are performed annually in
which hydrogels based material is extensively used. According to report
published by American Society of Plastic Surgeons 2017, around 290,467 breast
augmentation surgeries were performed in 2016, which increased to 300,378 in
2017. High prevalence of the chronic disease such as cancer and cardiovascular
disease and extensive research and development by pharmaceutical and biotech
companies for development of innovative products are driving market growth.
According to the estimation of Pharmaceutical Research and Manufacturers of
America (PhRMA), in 2017, pharmaceutical industry invested around US$ 0.8
billion to US$ 1.7 billion per company on research and development activities.
Europe is projected to witness significant growth in the medical grade hydrogel
market.
Hydrogel are hydrophilic, three
dimensional, and cross-linked polymer chain, which has property to absorb
different fluids. They resemble body tissue with respect to their ability to
absorb large amount of water. The property to absorb different types of the
fluid makes hydrogel suitable for many medical applications. As human body consist
of large amount of water, therefore hydrogels are highly biocompatible and can
be used as carrier for many active ingredients. Being biodegradable, hydrogels
are harmless as compared to other polymers. Hydrogels such as polysaccharides
and polypeptides are of natural origin, whereas artificial hydrogels include
N-isopropyl acrylamide and Jeffamine M-1000 acrylamide. Artificial hydrogels
carries superior mechanical strength, longer shelf life, and larger capacity to
absorb water. This hydrogels are based on the type of material from which they
originate, shows varying response to pH, temperature, light, and different
chemicals. The pH responsive hydrogels possess chemical/physical properties at
specific pH. Gastric targeted drug such as small intestine, stomach, and colon
targeted drug delivery system has been under development specifically for
chronic conditions such as colon and stomach cancer. Cell modelling is
conducted to mimic GI tract cell, based on pH characteristics. Light responsive
hydrogels can be used in gene delivery, drug delivery, and biomedical sensors.
* The sample copy includes:
Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report
Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1906
Market Dynamics
Medical grade hydrogel is gaining
significant traction as the novel carrier, which can be used in various
products targeted for different indications. Currently medical grade hydrogel
has major application in wound dressings, plastic surgery, cosmetics,
orthopedics, and immunotherapy. Increasing research on utility and capability
of medical grade hydrogel is expected to propel growth of the medical grade
hydrogel market. Hydrogels is currently widely used as material for plastic and
reconstructive surgery. Therefore, increasing number of reconstructive surgery
is expected to drive growth of market. Extensive research is being conducted on
hydrogels for their application in novel drug delivery systems such as
controlled release delivery and sustained release delivery to improve the
prospect of hydrogels as novel excipient and carrier. Moreover, high prevalence
of chronic disease such as cancer is propelling growth of the market. For
instance, according to the data published by International Journal of Pharma
Sciences and Research (IJPSR), around 9 million deaths occurred due to cancer
in 2015, and around 11.4 million people are estimated to die due to cancer by
2030. Such high number of deaths is propelling demand for development of novel
molecule with effective targeting of drug towards diseased organ, which can be
achieved with hydrogel due to its extracellular characteristics, which would
also decrease side effects associated to anti-cancer drugs. Hydrogel act as an
effective carrier in skin cancer. Hydrogel such as hyaluronic acid is used as
tissue filler for plastic reconstruction surgery such as breast reconstruction.
This surgery is conducted if breast cancer treatment compels to remove affected
tissue mass. Increasing adoption of immunotherapy to treat various disease such
as asthma and Crohn’s disease are expected to fuel growth of the medical grade
hydrogel market. A nanovector composed of peptide-based nanofibrous hydrogel
can condense DNA to result in strong immune responses against disease such as
HIV. HIV is one of the major cause of deaths globally.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/medical-grade-hydrogel-market-1906
According to UNAIDS factsheet, in
2016, around 36.7 million were suffering from HIV worldwide. Hydrogels are
majorly used in proteomics and electrophoresis as replacement to other types of
polymers. Smart hydrogels and tissue engineering are future research areas for
hydrogel, which would aid in medical application and drive growth for medical
grade hydrogel market.
Competitive Landscape
Key players operating in the
medical grade hydrogel market include 3M, ConvaTec, Integra Lifescience
Holdings Corporation, Smith & Nephew plc, United Axelgaard, Coloplast, Paul
Hartmann, Medtronic plc, and Ocular Therapeutix.
Companies are launching novel
products in order to gain larger market share and establish dominance over
other competitors. For instance, Integra LifeSciences launched hydrogel-based
product named Revize/Revize-X Collagen Matrix for Plastic and Reconstructive
Surgery in October 2017.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1906
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent Market
Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment